Anxiety treatment for Boynton Beach — SSRI dosing done right, CBT that works.

For Boynton Beach residents, RECO Integrated Psychiatry sits twelve minutes south on Federal Highway — close enough that weekly SSRI titration visits and therapy referrals fit into an existing schedule rather than replacing it. The practice treats anxiety at specialist doses (sertraline 150-200 mg for GAD or OCD, escitalopram 20 mg, paroxetine 40-60 mg for social anxiety), sequences comorbid diagnoses explicitly, and refers to disorder-specific CBT — ERP for OCD, interoceptive exposure for panic, in-vivo exposure for social anxiety. Benzodiazepines are prescribed with defined tapers and non-benzodiazepine alternatives rather than open-ended maintenance.

Boynton Beach sits seven miles north of RECO Integrated Psychiatry’s Delray Beach office along Federal Highway — a twelve-minute drive that, for residents of Renaissance Commons, Ocean Ridge, or Quantum Park, is shorter than the run to the nearest Publix. That geographic reality matters clinically. Anxiety treatment depends on frequent follow-ups during SSRI titration, and adherence collapses when the drive itself becomes a reason to skip. Patients in Hunters Run and Briny Breezes reach the office in under twenty minutes off I-95 or A1A.

The disorder distinctions that change treatment

Generalized anxiety disorder, panic disorder, social anxiety disorder, and obsessive-compulsive disorder are frequently collapsed into a single “anxiety” label in casual conversation and even in many primary care encounters. Clinically, they respond to different therapy protocols and often to different medication dosing. A patient with untreated OCD does not benefit from the CBT script that helps GAD, and a patient with panic disorder needs interoceptive exposure — deliberately reproducing the somatic sensations of a panic attack in a controlled setting — that a therapist trained only in generalized cognitive restructuring will not deliver.

Intake at RECO uses disorder-specific instruments: the GAD-7 for generalized anxiety, the Panic Disorder Severity Scale (PDSS), the Liebowitz Social Anxiety Scale (LSAS), and the Y-BOCS for obsessive-compulsive disorder. The intake note names a DSM-5-TR primary diagnosis rather than a generic “anxiety NOS” — which matters when a subsequent clinician or insurer needs to understand what was actually being treated.

Comorbidity is the rule rather than the exception. Panic with GAD, social anxiety with OCD, and any of these with major depressive disorder each require sequencing decisions: which condition is driving the most functional impairment, which is likely to respond first, and how a medication chosen for one will affect the other. The written plan is explicit about that order.

SSRI dosing for anxiety versus depression

Effective SSRI doses for anxiety disorders typically sit at the upper end of the depression range. Sertraline commonly reaches 150-200 mg for GAD or OCD; escitalopram often needs the full 20 mg; paroxetine target ranges climb into 40-60 mg for social anxiety and panic. Under-dosing is one of the most common reasons a patient arrives at a specialist saying SSRIs did not work — the molecule was correct, the dose was not.

The opposite failure mode is initiation activation. Serotonergic agents can transiently worsen anxiety in the first one to two weeks, and anxious patients are unusually sensitive to that early jitter. The default at RECO is to start at roughly half the usual initiating dose — sertraline 25 mg rather than 50 mg, escitalopram 5 mg rather than 10 mg — and to titrate on a slower schedule than a depression protocol would use. Same ceiling, longer runway.

Getting this right requires visit frequency during titration. Anxiety follow-up in the first two months is scheduled at two- to three-week intervals, not the six- to eight-week cadence typical of maintenance treatment. Telepsychiatry visits handle the interim checks when driving in from Boynton is redundant.

Augmentation and second-line strategies

SSRI partial response in GAD is augmented with buspirone at 20-60 mg per day; the evidence base for buspirone augmentation is stronger than for cross-titrating to an SNRI in this population. Panic disorder partial responders benefit more from adding CBT with interoceptive exposure than from further medication changes — the reason panic recurs is usually not undertreated serotonin, it is a preserved conditioned fear of the physical sensations themselves.

OCD partial responders are augmented with low-dose aripiprazole (2-5 mg) or risperidone. The antipsychotic-augmentation evidence in OCD is more robust than the evidence for cycling through additional SSRIs, which is worth naming because many outpatient plans move patients through three or four SSRIs before considering augmentation.

Propranolol has a narrow but real role in situational performance anxiety — musicians, presenters, patients whose social anxiety is dominated by autonomic symptoms. Gabapentin and hydroxyzine cover PRN needs without the dependence profile of benzodiazepines and are the default as-needed options at RECO.

Benzodiazepines: when we do and don’t prescribe

Benzodiazepines have a legitimate role in short-term crisis stabilization and in a small number of narrow chronic indications, most commonly panic disorder refractory to adequate SSRI and CBT trials. They also blunt extinction learning during exposure-based CBT — the mechanism CBT relies on to durably reduce anxiety — and carry dose-dependent risks of cognitive impairment, tolerance, and dependence. For patients with any documented substance use history, the default at RECO is not to prescribe.

When a benzodiazepine is prescribed, the plan is written with a taper timeline and a defined non-benzodiazepine alternative — usually gabapentin, hydroxyzine, or propranolol — rather than open-ended maintenance. Patients arriving on chronic benzodiazepines from another prescriber are not abruptly discontinued; a scheduled cross-taper coordinated with the initiation of an adequately dosed SSRI is written into the plan from the first visit.

What to expect on your first visit

The intake appointment runs 60 to 75 minutes and covers psychiatric history, current symptoms, prior medication trials with dose and duration, medical comorbidities, substance use screening, and family psychiatric history. Symptom-specific scales — GAD-7, PDSS, LSAS, or Y-BOCS — are administered based on presenting concerns. Basic labs (TSH, CBC, CMP, B12) are ordered when they have not been drawn recently, because thyroid dysfunction mimics an anxiety disorder often enough to be worth ruling out before adjusting psychotropics.

The visit ends with a written treatment plan: a named DSM-5-TR diagnosis, a medication decision with dose and titration schedule, a therapy referral matched to the diagnosis (ERP for OCD, interoceptive exposure for panic, in-vivo exposure for social anxiety, standard CBT or ACT for GAD), and a follow-up appointment scheduled within two to three weeks. For patients with prominent depressive comorbidity who have failed two adequate antidepressant trials, rTMS and Spravato (esketamine) are discussed as adjunctive options rather than as first-line anxiety treatment.

Insurance and admissions from Boynton Beach

RECO Integrated Psychiatry is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS. Insurance verification is completed before the first visit so the copay and any remaining deductible are known at check-in rather than arriving as a surprise afterward. Superbills for out-of-network reimbursement are issued on request.

The Delray office is a twelve-minute drive south from Renaissance Commons via Federal Highway or I-95. For patients in Ocean Ridge and Briny Breezes the coastal A1A route is comparable in time. Telepsychiatry follow-up is available for medication management visits after the in-person intake, which keeps titration on schedule without adding a weekly commute.

Serving residents of: Renaissance Commons, Ocean Ridge, Quantum Park, Hunters Run, Briny Breezes.